Glucagon selectively increases splanchnic blood flow in patients with well‐compensated cirrhosis

Hepatology

Volumn 8, Issue 6, 1988, Pages 1501-1505

  Lee, Samuel S ^a   Moreau, Richard ^a   Hadengue, Antoine ^a   Cerini, Raimondo ^a   Koshy, Abraham ^a   Lebrec, Didier ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON;

ADULT; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PORTOCAVAL SHUNT; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW;

ADULT; AGED; BLOOD PRESSURE; FEMALE; GLUCAGON; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGE; SPLANCHNIC CIRCULATION; SUPPORT, NON-U.S. GOV'T;

EID: 0024268894     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840080606     Document Type: Article

References (38)

1. Reduction of intrahepatic vascular space in the pathogenesis of portal hypertension. In vitro and in vivo studies in the rat
2. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension
3. Glucagon and the circulation
4. Splanchnic hemodynamic responses to glucagon
5. The effect of glucagon on hepatic blood flow. An experimental study in the dog
6. Inability of glucagon to increase glomerular filtration rate in dogs with experimental cirrhosis and ascites
7. Secretion and degradation of insulin and glucagon in carbon tetrachloride‐induced liver injury rats
8. Systemic and portal glucagon levels in two rat models of portal hypertension. The relation to portal systemic shunting and portal venous inflow (Abstract)
9. Elevated plasma glucagon levels in cirrhosis of the liver
10. Hyperglucagonemia in Laënnec's cirrhosis. The role of portal‐systemic shunting
11. Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage
12. The effects of glucagon on systemic and hepatosplanchnic haemodynamics and on net peripheral and hepatosplanchnic balance of glucose, lactic and pyruvic acids in normal subjects and cirrhotics
13. Effects of food intake and various extrinsic hormones on portal blood flow in patients with liver cirrhosis demonstrated by pulsed doppler with the octoson
14. Transection of the oesophagus for bleeding oesophageal varices
15. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol
16. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine
17. Some statistical methods useful in circulation research
18. The mediastinum in portal hypertension
19. Measurement or azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis
20. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis
21. Measurement of azygos blood flow by a continuous thermodilution method in liver disease
22. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis
23. Oxygen and bile acid content in the azygos blood. Clues to the azygos derivation in patients with portal hypertension
24. Role of glucagon in splanchnic hyperemia of chronic portal hypertension
25. Effects of nitroglycerin on forearm haemodynamics in patients with cirrhosis
26. 2 utilization in patients with cirrhosis: evidence for a subclinical tissue hypoxia (Abstract)
27. Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis
28. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites
29. Portal hemodynamics during nitroglycerin administration in cirrhotic patients
30. Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis
31. Studies on the pharmacology of glucagon
32. Characterization of glucagon‐induced changes in rate contractility and cyclic AMP levels in isolated cardiac preparations of the rat and guinea pig
33. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon
34. Influence de glucagon sur le taux des catécholamines surrénaliennes chez le rat
35. Elevation of plasma epinephrine levels produced by glucagon in vivo
36. The mechanism of glucagon‐induced natriuresis in dogs
37. Importance of the liver during glucagon‐mediated increases in canine renal hemodynamics
38. Modification by glucagon of the splanchnic vascular responses to activation of the sympathicoad‐renal system